Literature DB >> 27356029

Targeting of non-cycling cells of hypoxic tumors.

E Bourseau-Guilmain1, J A Menard1, M Belting1,2.   

Abstract

Entities:  

Keywords:  cancer; caveolin-1; endocytosis; hypoxia; targeted therapy

Mesh：

Year:  2016        PMID： 27356029      PMCID： PMC5105916          DOI： 10.1080/15384101.2016.1204867

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 2.  Engineered protein scaffolds as next-generation antibody therapeutics.

Authors:  Michaela Gebauer; Arne Skerra
Journal:  Curr Opin Chem Biol       Date:  2009-06-06       Impact factor: 8.822

Review 3.  Antibody therapeutics in cancer.

Authors:  Mark X Sliwkowski; Ira Mellman
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

Review 4.  Derailed endocytosis: an emerging feature of cancer.

Authors:  Yaron Mosesson; Gordon B Mills; Yosef Yarden
Journal:  Nat Rev Cancer       Date:  2008-11       Impact factor: 60.716

5.  Regulation of endocytosis via the oxygen-sensing pathway.

Authors:  Yi Wang; Olga Roche; Mathew S Yan; Greg Finak; Andrew J Evans; Julie L Metcalf; Bridgid E Hast; Sara C Hanna; Bill Wondergem; Kyle A Furge; Meredith S Irwin; William Y Kim; Bin T Teh; Sergio Grinstein; Morag Park; Philip A Marsden; Michael Ohh
Journal:  Nat Med       Date:  2009-03-01       Impact factor: 53.440

6.  Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells.

Authors:  E Bourseau-Guilmain; J A Menard; E Lindqvist; V Indira Chandran; H C Christianson; M Cerezo Magaña; J Lidfeldt; G Marko-Varga; C Welinder; M Belting
Journal:  Nat Commun       Date:  2016-04-20       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.